PN-943 / Protagonist Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PN-943 / Protagonist Therap
NCT04504383 / 2019-004469-41: PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)

Completed
2
169
Europe, Canada, US, RoW
PN-943, Placebo
Protagonist Therapeutics, Inc.
Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe
02/23
02/23

Download Options